• HeartCore Reports Third Quarter 2024 Financial Results

    ソース: Nasdaq GlobeNewswire / 14 11 2024 07:30:00   America/Chicago

    Q3 2024 Revenues Increased 281% to $17.9 Million

    Q3 2024 Net Income Increased 526% to $10.8 Million

    NEW YORK and TOKYO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended September 30, 2024.

    Third Quarter 2024 and Recent Operational Highlights

    • Regained compliance with Nasdaq Listing Requirements
    • Expanded CMS platform offering into a SaaS delivery model
    • Entered into a sales collaboration with Tosho Computer Systems Co., Ltd.
    • Announced transition from annual contracts to multi-year agreements for core software business contracts
    • Partnered with NTT Data Business Brains Corporation to enhance website development service capabilities
    • Achieved top market share in Japan for nine consecutive years
    • Awarded new contract from Fourmix Co., Ltd. to implement CMS platform
    • Announced Go IPO Client, SBC Medical Group Holdings Incorporated, began trading on the Nasdaq Stock Exchange
    • Partnered with INCUDATA Corp. to enhance corporate digital marketing strategies
    • Announced Go IPO Client, BloomZ Inc., began trading on the Nasdaq Stock Exchange
    • Authorized second dividend payment of $0.02 per share
    • Partnered with Hitachi Systems, Ltd. to offer combined package of HeartCore CMS and GRED Web Security Assessment Cloud

    Management Commentary
    “I am pleased to announce the strongest quarter of HeartCore’s history, supported by the progress made across our Go IPO business,” said HeartCore CEO Sumitaka Kanno. “The third quarter saw two new Go IPO clients successfully listed on the Nasdaq. The warrants and ordinary shares received from these deals contributed to our highest financial results since the inception of the service, driving us into profitable operations for the quarter and year-to-date. This quarter’s results showcased the immense value of our consulting business, and with an optimistic outlook on the U.S. IPO market for Japanese companies, we anticipate closing additional deals over the next several months that will further support the growth of our Go IPO business. We continue to remain in serious discussions with prospective Go IPO clients and look forward to sharing future wins as they come.”

    “We also accomplished key developments in our software business, positioning us for sustained and predictable growth in the coming quarters. First, we transitioned towards offering multi-year software licensing agreements to our customers, a move designed to generate recurring revenue streams and enhance our margin profile. Furthermore, we added a SaaS delivery model for our CMS platform designed to support our sales and marketing team to tap into a new pool of prospective customers. While Go IPO contains the prospect of significant upside, our adjustments in the software business model are intended to create more stable, durable, and long-term revenue for future quarters. We look forward to continuing driving growth across both arms of the business and carrying this momentum into 2025.”

    Third Quarter 2024 Financial Results
    Revenues increased 281% to $17.9 million compared to $4.7 million in the same period last year. The increase was primarily due to revenue from warrants and ordinary shares associated with the successful listing of two Go IPO consulting service clients.

    Gross profit increased 1,640% to $14.4 million compared to $0.8 million in the same period last year. The increase was primarily due to the aforementioned reason above.

    Operating expenses decreased to $2.3 million compared to $2.6 million in the same period last year. The improvement was primarily due to lower selling, general and administrative, and research and development expenses.

    Net income increased 526% to $10.8 million or $0.53 per diluted share compared to a net loss of $2.5 million or $(0.11) per diluted share, in the same period last year.

    As of September 30, 2024, the Company had cash and cash equivalents of $1.2 million compared to $1.0 million on December 31, 2023.

    Nine-Months 2024 Financial Results
    Revenues increased 46% to $27.0 million compared to $18.5 million in the same period last year. The increase was primarily because revenue recognized from warrants and ordinary shares associated with the successful listing of two Go IPO consulting service clients in current periods was greater than that of recognized in the nine months ended September 30, 2023.

    Gross profit increased 117% to $17.3 million compared to $8.0 million in the same period last year. The increase was primarily due to the aforementioned reason above.

    Operating expenses decreased to $7.3 million compared to $8.9 million in the same period last year. The decrease was primarily due to lower selling and general and administrative expenses.

    Net income increased 506% to $7.1 million or $0.37 per diluted share compared to a net loss of $1.8 million or $(0.07) per diluted share, in the same period last year.

    About HeartCore Enterprises, Inc.
    Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading enterprise software and consulting services company. HeartCore offers Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore’s customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. HeartCore’s GO IPOSM consulting services helps Japanese-based companies go public in the U.S. Additional information about the Company's products and services is available at and https://heartcore-enterprises.com/.

    Forward-Looking Statements
    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this press release are forward-looking statements. In some cases, forward-looking statements can be identified by words such as “believed,” “intend,” “expect,” “anticipate,” “plan,” “potential,” “continue,” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore’s filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore’s control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore’s current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

    HeartCore Investor Relations Contact:
    Gateway Group, Inc.
    Matt Glover and John Yi
    HTCR@gateway-grp.com
    (949) 574-3860

    HeartCore Enterprises, Inc.
    Consolidated Balance Sheets
         
      September 30, December 31,
      2024 2023
      (Unaudited)  
    ASSETS
         
    Current assets:    
    Cash and cash equivalents$1,232,117 $1,012,479 
    Accounts receivable 2,578,855  2,623,682 
    Investments in marketable securities 7,349,575  642,348 
    Investment in equity securities -  300,000 
    Prepaid expenses 769,183  536,865 
    Current portion of long-term note receivable 100,000  100,000 
    Due from related party 43,852  44,758 
    Other current assets 177,381  234,761 
    Total current assets 12,250,963  5,494,893 
         
    Non-current assets:    
    Accounts receivable, non-current 766,972  - 
    Property and equipment, net 663,447  763,730 
    Operating lease right-of-use assets 2,184,344  2,467,889 
    Intangible asset, net 4,037,500  4,515,625 
    Goodwill 3,276,441  3,276,441 
    Long-term investment in SAFE 350,000  - 
    Long-term investment in equity securities 300,000  - 
    Long-term investment in warrants 551,787  2,004,308 
    Long-term note receivable 200,000  200,000 
    Deferred tax assets 392,617  369,436 
    Security deposits 336,117  348,428 
    Long-term loan receivable from related party 146,354  182,946 
    Other non-current assets 15,812  71 
    Total non-current assets 13,221,391  14,128,874 
         
    Total assets$25,472,354 $19,623,767 
         
    LIABILITIES AND SHAREHOLDERS' EQUITY
         
    Current liabilities:    
    Accounts payable and accrued expenses$1,779,799 $1,757,038 
    Accounts payable and accrued expenses - related party 28,772  - 
    Accrued payroll and other employee costs 633,514  723,305 
    Due to related party 1,438  1,476 
    Short-term debt -  135,937 
    Current portion of long-term debts 462,121  371,783 
    Insurance premium financing 65,392  - 
    Factoring liability 305,472  562,767 
    Operating lease liabilities, current 382,594  396,535 
    Finance lease liabilities, current 17,375  17,445 
    Income tax payables 170,453  162,689 
    Deferred revenue 1,927,582  2,166,175 
    Other current liabilities 756,766  216,405 
    Total current liabilities 6,531,278  6,511,555 
      -   
    Non-current liabilities:    
    Long-term debts 1,382,048  1,770,352 
    Operating lease liabilities, non-current 1,859,948  2,135,160 
    Finance lease liabilities, non-current 52,005  66,779 
    Deferred tax liabilities 1,130,500  1,264,375 
    Other non-current liabilities 200,818  208,732 
    Total non-current liabilities 4,625,319  5,445,398 
         
    Total liabilities 11,156,597  11,956,953 
         
    Shareholders' equity:    
    Preferred shares ($0.0001 par value, 20,000,000 shares authorized, no shares issued and outstanding as of September 30, 2024 and December 31, 2023) -  - 
    Common shares ($0.0001 par value, 200,000,000 shares authorized; 20,864,144 and 20,842,690 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively) 2,085  2,083 
    Additional paid-in capital 18,997,059  19,594,801 
    Accumulated deficit (6,990,113) (14,763,469)
    Accumulated other comprehensive income 392,397  331,881 
    Total HeartCore Enterprises, Inc. shareholders' equity 12,401,428  5,165,296 
    Non-controlling interests 1,914,329  2,501,518 
    Total shareholders' equity 14,315,757  7,666,814 
         
    Total liabilities and shareholders' equity$25,472,354 $19,623,767 



    HeartCore Enterprises, Inc.
    Unaudited Consolidated Statements of Operations and Comprehensive Income (Loss)
                
                
      For the nine months ended September 30,   For the three months ended September 30,
      2024  2023  2024  2023
                
    Revenues$26,963,531  $18,518,431  $17,850,411  $4,688,908 
    Cost of revenues 9,708,074   10,548,245   3,433,024   3,860,241 
    Gross profit 17,255,457   7,970,186   14,417,387   828,667 
                
    Operating expenses:           
    Selling expenses 642,225   1,330,747   243,110   274,043 
    General and administrative expenses 6,395,429   7,305,392   1,966,717   2,172,298 
    Research and development expenses 307,931   289,303   107,529   170,071 
    Total operating expenses 7,345,585   8,925,442   2,317,356   2,616,412 
                
    Income (loss) from operations 9,909,872   (955,256)  12,100,031   (1,787,745)
                
    Other income (expenses):           
    Changes in fair value of investments in marketable securities (308,059)  (500,762)  122,272   (271,740)
    Changes in fair value of investment in warrants 1,631,700   (294,565)  2,869,407   (460,672)
    Loss on sale of warrants (3,970,628)  -   (3,970,628)  - 
    Interest income 15,557   64,633   10,933   14,363 
    Interest expenses (105,094)  (125,073)  (31,393)  (42,619)
    Other income 158,914   176,641   24,040   52,640 
    Other expenses (131,507)  (62,701)  (82,457)  (25,947)
    Total other expenses (2,709,117)  (741,827)  (1,057,826)  (733,975)
                
    Income (loss) before income tax provision 7,200,755   (1,697,083)  11,042,205   (2,521,720)
                
    Income tax expense 72,945   58,859   225,275   19,413 
                
    Net income (loss) 7,127,810   (1,755,942)  10,816,930   (2,541,133)
    Less: net loss attributable to non-controlling interests (645,546)  (419,211)  (240,876)  (233,913)
    Net income (loss) attributable to HeartCore Enterprises, Inc.$7,773,356  $(1,336,731) $11,057,806  $(2,307,220)
                
    Other comprehensive income (loss):           
    Foreign currency translation adjustment 51,678   (85,244)  65,503   (90,743)
                
    Total comprehensive income (loss) 7,179,488   (1,841,186)  10,882,433   (2,631,876)
    Less: comprehensive loss attributable to non-controlling interests (654,384)  (422,352)  (241,913)  (235,094)
    Comprehensive income (loss) attributable to HeartCore Enterprises, Inc.$7,833,872  $(1,418,834) $11,124,346  $(2,396,782)
                
    Net income (loss) per common share attributable to HeartCore Enterprises, Inc.         
    Basic$0.37  $(0.07) $0.53  $(0.11)
    Diluted$0.37  $(0.07) $0.53  $(0.11)
                
    Weighted average common shares outstanding           
    Basic 20,861,012   20,257,020   20,864,144   20,842,690 
    Diluted 20,861,012   20,257,020   20,864,144   20,842,690 



         
    HeartCore Enterprises, Inc.
    Unaudited Consolidated Statements of Cash Flows
         
      For the nine months ended September 30,
      2024 2023
         
    Cash flows from operating activities    
    Net income (loss)$7,127,810 $(1,755,942)
    Adjustments to reconcile net income (loss) to net cash flows    
    used in operating activities:    
    Depreciation and amortization expenses 561,659  495,200 
    Loss (gain) on disposal of property and equipment 1,894  (4,737)
    Amortization of debt issuance costs 3,791  2,257 
    Non-cash lease expense 272,208  254,876 
    Loss (gain) on termination of lease (469) 76 
    Deferred income taxes (163,199) (109,690)
    Stock-based compensation 236,826  1,267,699 
    Marketable securities received as noncash consideration (572,010) - 
    Warrants received as noncash consideration (12,969,683) (4,009,335)
    Changes in fair value of investments in marketable securities 308,059  500,762 
    Changes in fair value of investment in warrants (1,631,700) 294,565 
    Loss on sale of warrants 3,970,628  - 
    Changes in assets and liabilities:    
    Accounts receivable (685,531) (322,583)
    Prepaid expenses (72,315) 187,269 
    Other assets 40,761  (23,982)
    Accounts payable and accrued expenses 34,752  597,247 
    Accounts payable and accrued expenses - related party 28,315  - 
    Accrued payroll and other employee costs (68,323) 7,471 
    Due to related party (7) 7,562 
    Operating lease liabilities (275,850) (231,499)
    Income tax payables 17,971  101,058 
    Deferred revenue (205,109) 200,256 
    Other liabilities 540,008  83,809 
    Net cash flows used in operating activities (3,499,514) (2,457,661)
         
    Cash flows from investing activities    
    Purchases of property and equipment (4,134) (516,658)
    Proceeds from disposal of property and equipment -  24,935 
    Advance on note receivable -  (600,000)
    Purchase of long-term investment in SAFE (350,000) - 
    Net proceeds from sale of warrants 5,640,000  - 
    Repayment of loan provided to related party 31,457  34,823 
    Payment for acquisition of subsidiary, net of cash acquired -  (724,910)
    Net cash flows provided by (used in) investing activities 5,317,323  (1,781,810)
         
    Cash flows from financing activities    
    Payments for finance leases (12,568) (16,537)
    Proceeds from short-term and long-term debts 68,138  219,427 
    Repayment of short-term and long-term debts (453,048) (584,779)
    Repayment of insurance premium financing (107,297) (266,756)
    Net proceeds from factoring arrangement -  217,250 
    Net repayment of factoring arrangement (257,295) - 
    Payments for debt issuance costs -  (656)
    Distribution of dividends (834,566) - 
    Capital contribution from non-controlling shareholder 67,195  - 
    Net cash flows used in financing activities (1,529,441) (432,051)
         
    Effect of exchange rate changes (68,730) (306,239)
         
    Net change in cash and cash equivalents 219,638  (4,977,761)
         
    Cash and cash equivalents - beginning of the period 1,012,479  7,177,326 
         
    Cash and cash equivalents - end of the period$1,232,117 $2,199,565 
         
    Supplemental cash flow disclosures:    
    Interest paid$104,880 $59,290 
    Income taxes paid$201,035 $91,657 
         
    Non-cash investing and financing transactions    
    Operating lease right-of-use assets obtained in exchange for operating lease liabilities$125,735 $317,040 
    Finance lease right-of-use assets obtained in exchange for finance lease liabilities$- $93,117 
    Remeasurement of operating lease liabilities and right-of-use assets due to lease modification$- $12,579 
    Insurance premium financing$172,689 $389,035 
    Liabilities assumed in connection with purchase of property and equipment$- $9,602 
    Common shares issued for acquisition of subsidiary$- $3,150,000 
    Warrants converted to marketable securities$6,443,276 $1,257,868 
         

    Primary Logo

シェアする